This transformation, known as lineage plasticity, enables cancer cells to evade many conventional therapies, such as androgen receptor (AR)-targeted therapies and taxane-based chemotherapies, rendering them highly resistant and contributing to rapid disease progression [5, 6]. Here, AR is linked to cancer.